Evaluation of RC28-E Injection in Diabetic Retinopathy

Clinical trial NCT04782128 · UNKNOWN

Trial details

NCT number: NCT04782128
Sponsor: RemeGen Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2021-05-25
Primary completion: 2024-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.